Catenaa, Tuesday, July 29, 2025- AstraZeneca has increasing business in the US with 50% revenue expected from the state side by 2030, amidst reports that the UK-listed company might come to Wall Street. CEO Pascal Soriot on Tuesday said the UK-listed company had many reasons to be in the US, adding that it was “rapidly […]

Catenaa, Friday, July 04, 2025- London IPO fundraising in the first half of 2025 fell to a thirty-year low as the UK failed to attract huge listings and as companies sought listings in New York. According to new data from Dealogic, the five debuts on the London market in the first six months of 2025 […]